APA (7th ed.) Citation

TT, H., JR, N., C, B., J, C., D, N., S, N., . . . JM, L. (2026). DHX9 inhibition enhances paclitaxel sensitivity by inducing mitotic failure in ovarian and endometrial cancers. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.MCT-25-1196

Chicago Style (17th ed.) Citation

TT, Huang, Nair JR, Bowen C, Castro J, Nousome D, Nayak S, Silver SJ, and Lee JM. "DHX9 Inhibition Enhances Paclitaxel Sensitivity by Inducing Mitotic Failure in Ovarian and Endometrial Cancers." Molecular Cancer Therapeutics 2026. https://doi.org/10.1158/1535-7163.MCT-25-1196.

MLA (9th ed.) Citation

TT, Huang, et al. "DHX9 Inhibition Enhances Paclitaxel Sensitivity by Inducing Mitotic Failure in Ovarian and Endometrial Cancers." Molecular Cancer Therapeutics, 2026, https://doi.org/10.1158/1535-7163.MCT-25-1196.